Endari Will Be a New Specialty Med for Sickle Cell Disease

December 2017

Endari (en-DAR-ee, L-glutamine) is the first sickle cell treatment to be approved in almost 20 years.

Endari works by stopping "sickle-shaped" red blood cells from blocking blood flow...which helps prevent pain crises, organ damage, and other symptoms.

It'll likely be saved for patients who are already on max doses of hydroxyurea...and still have 2 or more pain crises per year.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Practice Ensure Your Patients Get In-Date Meds
Vaccines Be Aware of the Differences Between Shingrix and Zostavax
Insulin Think of Fiasp as Faster-Acting NovoLog
Medication Errors Remember "One Shake, Two Shake" With Reconstituted Oral Meds
Supplements Watch for Patients Picking Up Cinnamon for Diabetes
Constipation Symproic Will Join Movantik and Relistor for Opioid-Induced Constipation
Medication Errors Keep Oral Cyclosporine Products Straight
Cardiology Help Your Spironolactone and Eplerenone Patients Take Their Med Safely
Acne Oral Antibiotics for Acne Should Usually Be Limited to 3 to 4 Months
Gastroenterology Be Familiar With Meds That Are Held Before Colonoscopy
Sickle Cell Disease Endari Will Be a New Specialty Med for Sickle Cell Disease

Endari Will Be a New Specialty Med for Sickle Cell Disease

Practical advice for a better career, with unlimited access to CE

Table of Contents